Ubs Group Ag Anebulo Pharmaceuticals, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 25 shares of ANEB stock, worth $36. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 763
96.72%
Holding current value
$36
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$22.6 Million21.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$4.43 Million0.26% of portfolio
-
Mangrove Partners New York, NY2.53MShares$3.69 Million0.66% of portfolio
-
Lvw Advisors, LLC633KShares$923,4730.13% of portfolio
-
Morgan Stanley New York, NY420KShares$613,1910.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $37.4M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...